TOKYO -- Canon is adding cell culturing to its medical business portfolio, leveraging technology from its camera business to improve efficiency in a key area for the burgeoning field of regenerative medicine.
Biotechnology
Canon enters regenerative medicine with cell therapy acquisition
Manufacturer seeks to blend AI imaging with culturing tech to lower cost barriers
A scientist prepares stem cells at a British lab. Regenerative therapy is on track to become an $11 billion market by 2028. © Reuters
Read Next
.jpg?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
Latest on Biotechnology
